381 related articles for article (PubMed ID: 1902640)
1. Thrombolytic therapy.
Collen D; Lijnen HR
Ann N Y Acad Sci; 1991; 614():259-69. PubMed ID: 1902640
[No Abstract] [Full Text] [Related]
2. Thrombolytic therapy.
Goldhaber SZ
Adv Intern Med; 1999; 44():311-25. PubMed ID: 9929714
[No Abstract] [Full Text] [Related]
3. [Thrombolytic therapy in acute myocardial infarct].
Bode C; Baumann H; von Hodenberg E; Kübler W
Med Klin (Munich); 1992 Feb; 87(2):64-9. PubMed ID: 1542285
[No Abstract] [Full Text] [Related]
4. The current and future use of thrombolytic therapy.
Sherry S; Gustafson E
Annu Rev Pharmacol Toxicol; 1985; 25():413-31. PubMed ID: 3890708
[No Abstract] [Full Text] [Related]
5. Current state of thrombolytic therapy.
Vorchheimer DA
Curr Cardiol Rep; 1999 Sep; 1(3):212-20. PubMed ID: 10980844
[TBL] [Abstract][Full Text] [Related]
6. Thrombolytic agents for acute evolving myocardial infarction: comparative effects.
Sherry S
Ration Drug Ther; 1987 Jan; 21(1):1-9. PubMed ID: 3112866
[No Abstract] [Full Text] [Related]
7. New thrombolytic drugs in acute myocardial infarction: theoretical and practical considerations.
Verstraete M
Circulation; 1987 Aug; 76(2 Pt 2):II31-8. PubMed ID: 3111745
[No Abstract] [Full Text] [Related]
8. [Fibrinolytic agents--who benefits when?].
Weichert W; Seifried E
Ther Umsch; 1995 Oct; 52(10):652-60. PubMed ID: 7482376
[TBL] [Abstract][Full Text] [Related]
9. Is the streptokinase responsible for the endothelial injury and the platelet activation during fibrinolytic therapy?
Kolev K; Skopál J; Nagy Z; Machovich R
J Intern Med; 2001 May; 249(5):475-6. PubMed ID: 11350572
[No Abstract] [Full Text] [Related]
10. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
11. Newer thrombolytic drugs for acute myocardial infarction.
Reddy DS
Indian J Exp Biol; 1998 Jan; 36(1):1-15. PubMed ID: 9536645
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic treatment in acute myocardial infarction.
Acar J; Vahanian A; Michel PL; Slama M; Cormier B; Roger V
Semin Thromb Hemost; 1987 Apr; 13(2):186-200. PubMed ID: 2957791
[No Abstract] [Full Text] [Related]
13. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
14. Thrombolytic agents in clinical medicine.
Verstraete M
Adv Intern Med; 1988; 33():119-41. PubMed ID: 3125722
[No Abstract] [Full Text] [Related]
15. [Thrombolytic therapy].
Matsuda T
Nihon Rinsho; 1998 Oct; 56(10):2577-81. PubMed ID: 9796322
[TBL] [Abstract][Full Text] [Related]
16. Thrombolytic therapy.
Kakkar VV; Scully MF
Br Med Bull; 1978 May; 34(2):191-9. PubMed ID: 148935
[No Abstract] [Full Text] [Related]
17. Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.
Ludlam CA; Bennett B; Fox KA; Lowe GD; Reid AW
Blood Coagul Fibrinolysis; 1995 May; 6(3):273-85. PubMed ID: 7654941
[No Abstract] [Full Text] [Related]
18. [Tissue-type plasminogen activator and pro-urokinase--new fibrinolytic agents in the treatment of myocardial infarction].
Czyrski J
Wiad Lek; 1989 Apr; 42(7):450-2. PubMed ID: 2516932
[TBL] [Abstract][Full Text] [Related]
19. Another coronary reperfusion regimen.
Simoons ML
Lancet; 1995 Aug; 346(8971):324-5. PubMed ID: 7623525
[No Abstract] [Full Text] [Related]
20. [Tissue plasminogen activator: mechanism of action and thrombolytic properties].
Páramo JA; Collen D
Sangre (Barc); 1984; 29(4-C):767-73. PubMed ID: 6393389
[No Abstract] [Full Text] [Related]
[Next] [New Search]
